CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![Racing finish line-GettyImages-170615645]( "The State Of The Clinical Development Race")
The State Of The Clinical Development RaceEvery medicine reaching a patient has run a race from a crowded grid of candidates through the clinical development circuit to the market launch podium. Catch up on what’s in store for this season.
-
![resource heros]( "Examining The New Look For Biotech")
Examining The New Look For BiotechAccording to a recent episode of Citeline’s podcast series, “Small Biotechs, Big Decisions,” biotech is developing a new look that is leaner and savvier when it comes to working with partners.
-
![GettyImages-2166551077-AI-Artificial Intelligence-hands]( "How AI Is Revolutionizing Clinical Development")
How AI Is Revolutionizing Clinical DevelopmentArtificial intelligence is expanding from the preclinical phase of clinical trials into Phases I–III, where is it being used in protocol design, site selection, feasibility, and patient recruitment.
-
![GettyImages-2185301590-microscope-scientist-lab]( "Matching Pharmacovigilance Methodology To Organizational Scale")
Matching Pharmacovigilance Methodology To Organizational ScaleOne-size-fits-all doesn't work for safety signal detection. Discover a scalable framework that keeps expert judgment at the center — no matter how large your portfolio grows.
-
![AI medical cloud technology, analyzing patient health data, artificial intelligence agents, smart medical records, digital healthcare solutions-GettyImages-2229247291]( "AI Tools In Informed Consent: What Sponsors Need To Know About Risk")
AI Tools In Informed Consent: What Sponsors Need To Know About RiskAI tools carry different risks. See how they can impact participant communications, where bias and inaccuracies emerge, and why human review is critical to protecting study integrity.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
-
Accelerating Enrollment And Upholding Quality In Complex Oncology Trials5/5/2026
Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Biostatistical services, including SAP development, statistical programming in SAS, analysis, submission-ready services and statistical reports are customized and designed specifically to meet your project requirements.
Early Phase Experts
As a full-service contract research organization, Southern Star Research has the knowledge, industry relationships and technical expertise to get your early-phase clinical trial up and running safely and efficiently.
With a broad range of experience delivering Phase 1 Healthy Volunteer, First in Human, First in Patient and Phase 2 trials, we know just how important it is for your asset to succeed in the early development lifecycle. Our experienced team will help you obtain high-quality data that will appeal to future investors, meet the requirements of international regulatory bodies such as the FDA, EMA, PMDA, and Health Canada, and prepare your product for larger Phase 3 and 4 studies, partnerships, licensing, and sale.
Whatever your clinical trial needs, we can provide a flexible, bespoke solution that will not only meet your regulatory requirements but also position your product for commercial success.
In clinical research, data are everything. At inSeption Group, we understand the vital role data management plays in getting life-changing treatments to patients faster.
Change how you compete by getting the clinical data services and support you need. Medrio is here to help clinical trial sponsors and CROs build internal expertise and support any clinical trial data management needs.
More than just an electronic data collection tool, our robust clinical data management system combines an intuitive user interface, seamless online and offline data capture capabilities, and comprehensive data management for clinical trials in a single solution.
Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 phase 3c trials and 23 therapeutic areas.
CENTRAL LABORATORIES SOLUTIONS
- Medidata Research Alliance: Partnerships For Medical Progress
- Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle
- Integrate Your Data To Get The Full Picture
- Unlock The Hidden Value Of Your Data
- Glioblastoma Multiforme
- Feasibility As A Service From Consulting & Analytics
- Patient Journey Insights Beyond The Clinical Trial Window
- How The Sitetrove Diversity Module Can Diversify Studies
- Measuring A Wide Range Of CNS Effects In A Pharmacological Context
- Deliver Supply Without Friction. Maintain Control At Every Step
VIDEOS
- Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale
- Endpoint Named A Leader In Everest Group's 2025 Life Sciences RTSM Products PEAK Matrix Assessment
- Human Abuse Potential: Subjective Ratings
- Human Abuse Potential: Participant Recruitment
- Why Now? The Case For Disruptive Technology In Clinical Trials
NEWS
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®
- Altasciences Announces Chris Perkin Appointed To Board Of Directors; Marie-Hélène Raigneau Appointed Chief Executive Officer
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data